Sodium stearate has a backstory that stretches deep into the industrial revolution, where it played a part in the rise of both soap making and the early chemical industry. As manufacturers shifted from animal fats to vegetable sources, new methods shaped the routine production of high-purity sodium stearate for use in pharmaceuticals and personal care. Pharmacopeial grades such as BP, EP, and USP arrived as the health sector demanded tighter quality control. In my experience, reading older patents and regulatory archives, few compounds track the passage from backroom operations to high-tech, globally regulated products like sodium stearate. Its journey mirrors the maturation of pharmaceutical standards themselves, as regulators responded to growing public health needs and expectations for safety and proven composition.
Pharmaceutical-grade sodium stearate acts as the sodium salt of stearic acid, a fatty acid derived mostly from plant oils nowadays. You find it in rigid white granules or powder, odourless but faintly soapy to taste. In drug manufacturing, most folks know it as a lubricant or emulsifying agent, especially for capsules and tablets. Beyond pills, sodium stearate helps bind coatings, stabilizes emulsions, and even carries some relevance in topical creams. Demand rests on its versatile action across so many dosage forms. Reliable product quality stands front and center for drug makers, so each batch arrives tested for range of impurities, particle size, and moisture. Brands source from manufacturers who follow the rules spelled out in pharmacopeial texts, whether the British Pharmacopoeia (BP), European Pharmacopoeia (EP), or United States Pharmacopeia (USP).
Talking physical features, sodium stearate climbs the charts for stable, waxy salt chemistry. Melting point lands around 245°C and it dissolves freely in hot water, churning up a milky solution with basic pH. In everyday storage, it stays solid under ordinary temperatures, resists caking, and steers clear of chemical odor. Chemically, each molecule combines two stearic acid chains anchored to a single sodium ion, tallying up to a molecular weight of about 306.5 g/mol. Chemical stability helps it last on the shelf for years without spoilage. Structurally, the long hydrocarbon tail pulls away from polar solvents, which explains sodium stearate’s efficiency as an emulsifier. Its capacity for both hydrophilic and hydrophobic duties gives formulators extra flexibility. In labs, simple solubility, a near-neutral pH, and lack of reactivity line up in its favor for mixing with other pharmaceutical excipients.
Pharmacy suppliers publish technical data sheets that detail sodium stearate’s purity percentages, moisture levels, and heavy metal limits. Reputable sources tie sodium content within tight tolerances, check acid value to spot leftover stearic acid, and screen for minerals such as iron and magnesium. Transparent labeling remains crucial for safety and compliance, especially in pharma contexts. Every container should show product name, batch number, pharmacopeial grade, net weight, and expiry, plus details on storage. The information builds trust not just inside factories but all along the supply chain, so clinicians and regulators never have to wonder what’s inside a finished tablet or cream. From my conversations with QA managers, clear labeling speeds up recalls and avoids confusion where batches must be traced to source.
Sodium stearate production sticks to a few classic approaches. The core process starts when purified stearic acid reacts with high-purity sodium hydroxide, usually under gentle heat to protect the molecule from breaking down. This gives sodium stearate and water. Plant operators then dry, granulate, and screen the product. Multi-stage quality checks follow, where limits on trace contaminants like lead, arsenic, or residual solvents draw heavy scrutiny. In the pharmaceutical supply world, manufacturers audit production lines for good manufacturing practice (GMP) and document every variable that could impact composition. Batch-to-batch reproducibility holds such weight that companies invest in automated control systems just to eliminate variation. Raw material source tracing, equipment sanitization, and air-quality monitoring all become standard, unforgiving checkpoints.
Sodium stearate won’t sit idle in labs. When dissolved in water, it breaks into stearate ions and sodium ions. This property puts it to work as a starting block for further synthesis or chemical modifications. Stearate ions react with calcium, magnesium, or iron to make alternative salts for special applications. In food-contact or medical polymers, sodium stearate acts as a processing aid, where high temperatures might form simple byproducts with acids or bases. In my own hands-on work, blending sodium stearate with other excipients brought lessons about possible interactions; certain active pharmaceutical ingredients (APIs) love to bind or crystalize in its presence, sometimes shifting drug release rates. As a result, any new medicine seeking regulatory approval goes through tests to rule out unwanted side reactions.
Across markets, sodium stearate zigs and zags between labels. Some packages carry the technical name Sodium Octadecanoate, while others list INCI (International Nomenclature of Cosmetic Ingredients) as Sodium Stearate for creams and skin care. Variations like Stearic Acid, sodium salt pop up in ingredient lists for regulatory filings. Other times, sodium stearate slides in as a component of bespoke blends sold under trade names or private codes. The basic compound remains recognizable regardless of what name shows up, though every label should align with current pharmacopeial standards. In this tangle of synonyms, product quality draws from how well suppliers communicate the specifics, not from the language stamped on the pail.
Clinical purity demands strict testing, but factory hands also keep a close eye on safety guidelines during handling and transport. With proper ventilation and dust control, sodium stearate handles easily and rarely triggers acute reactions. Those filling capsules or mixing tablets wear gloves and face masks to keep minor skin or eye irritation at bay. Fire hazards slip down the list due to a high melting point and low dust combustibility. Cleanroom procedures and controlled storage conditions prevent product cross-contamination, cementing its place on ingredient lists for high-stakes therapies. Pharmaceutical firms maintain detailed records to satisfy auditors, and medical product recalls barely ever source back to sodium stearate mishaps. Still, waste management and spill cleanup protocols help local environments avoid contamination, especially when plants sit near waterways or public land. Workers in production learn early not to eat or drink in processing zones, as hygiene standards measure up to those expected for finished medicines.
Medicinal chemists reach for sodium stearate thanks to its track record across forms and formulations. In solid dosage forms, it lubricates tablets, easing them out of high-speed equipment. Capsule shells rely on its blending and anti-sticking prowess. Topical products use sodium stearate to stabilize creamy emulsions; it ensures prescription creams spread and store well without separating. The food and cosmetic markets lean on its same chemical behavior, but pharmaceutical contexts layer on more purity tests and cross-contamination defenses. I’ve seen how production teams choose suppliers not just by cost, but by how well sodium stearate integrates with proprietary recipes and how reliably certificates of analysis arrive. In some veterinary and industrial health products, sodium stearate secures a place when formulators chase consistent texture and controlled ingredient delivery.
Scientists working in formulation labs experiment with sodium stearate to approach old problems from new angles—extended-release mechanisms, faster dissolving tablets, greener production routes. As drug delivery systems grow in complexity, teams tinker with combinations, analyzing how sodium stearate interacts with competing lubricants or emulsifiers. Early studies dived into granule size and distribution, drawing links to pill stability and drug release profiles. Recently, R&D attention turned toward plant-based or synthetic alternatives, but sodium stearate’s legacy holds firm due to reliability and safety data stretching back decades. Journals report fresh advances in solid lipid nanoparticles, where sodium stearate features as a stabilizing force, boosting solubility for poorly absorbed drugs. In my exposure to preclinical research, grant money flows to projects seeking more sustainable sourcing of stearic acid, hoping to cut environmental footprints without disrupting established manufacturing routes.
Reviewing toxicology records, sodium stearate sits within the ranks of safest excipients involved in routine drug making. Acute oral toxicity reads low; even high doses in animal studies rarely turn up signs of lasting harm. Clinical literature tracks rare allergy-type reactions but no persistent organ damage. Most reported cases resolve with basic wound care or antihistamines. Regulators haven’t flagged it for genotoxicity, reproductive toxicity, or environmental persistence, though pharma-grade suppliers still screen every batch for trace toxins and allergens. In oral medicines, sodium stearate often passes straight through the gut without absorption, echoing dietary links to stearic acid found in chocolate and dairy. Long-term exposure reviews, including chronic inhalation or accidental workplace contamination, stick to conservative exposure limits far below thresholds for toxic effect. This safety profile anchors sodium stearate’s widespread use even in sensitive groups, like pediatric or geriatric patients, where ingredient transparency matters most.
Looking ahead, sodium stearate faces growing scrutiny and opportunity. The industry chases lower-carbon sourcing for all excipients, pressing suppliers toward tighter control over raw materials and carbon footprints. Biotechnologists explore microbial methods for manufacturing stearic acid, possibly shrinking the need for palm oil or animal fat feedstocks. With regulators ramping up demands for traceability and low-risk profiles, sodium stearate still draws investment for expanded role in new drug delivery platforms, transdermal films, and even gene therapy. Academic projects look for novel functionalizations—tinkering with stearate chains for added solubility or reactivity. As the pharma industry leans into precision medicine, sodium stearate’s established reliability may bump up against the hunger for personalized, micro-dosed forms, pushing suppliers to master ever-stricter particle sizing and purity targets. From factories to hospital shelves, sodium stearate’s next chapter ties itself tightly to technology upgrades, green chemistry, and relentless quality improvement.
People often look at a pill and don’t think about how smooth it feels or how well it holds together. Sodium stearate plays a behind-the-scenes role in the pharmaceutical world, acting as a lubricant in tablet production. This ingredient helps tablets press cleanly and break down once swallowed. Lubricants keep the pill-making machines running without jams, which helps avoid wasted materials and delays. For those of us who have worked around pill presses and blending rooms, a smooth production line is about more than convenience; it leads to better access and lower costs for everyone who relies on daily medicine.
Walk down the aisles of any pharmacy, and you’ll spot a shelf lined with creams and ointments. Sodium stearate brings structure and stability to these formulas. As a surfactant, it allows water and oil to blend, which gives ointments their creamy texture. This feat matters for those with sensitive skin or chronic conditions, as a stable cream can mean the difference between comfort and worry. In my experience working with dermatology groups, the right mix can make a cream feel comforting instead of greasy or sticky. Not every ingredient can accomplish that, which is why sodium stearate gets the nod from many compounding pharmacists.
If you’ve ever noticed your mouthwash foaming up a bit, sodium stearate likely contributed. Its unique chemical structure lets it act as a mild cleansing agent, helping active ingredients mix well and stay effective longer. Many medicated lozenges also use it to ensure that ingredients disperse evenly and that each batch tastes and feels the same. Consistency in over-the-counter treatments boosts trust. Over the years, countless patients have shared how much confidence a reliable experience brings, especially for children and older adults dealing with dry mouth or sore throat.
Soap bars, medicated cleansing bars, and gels designed for skin conditions use sodium stearate to keep their shape and quality during transport and shelf life. Temperature shifts, shipping delays, and humid climates can ruin poorly formulated products. Sodium stearate adds firmness and improves shelf stability, which means fewer losses during shipping. In global health settings where medication donations need to survive tough conditions, this quality carries real impact. Losing half a shipment of soap bars to melting or crumbling doesn’t just cost money—it risks health when hygiene supplies become scarce.
Sodium stearate shines in another important area: regulatory confidence. Both the European and U.S. pharmacopeias list it as safe for pharmaceutical manufacturing within designated limits. This approval doesn’t come easy; it’s earned through years of toxicology reports, manufacturing audits, and rigorous product testing. Trusted suppliers work within these guidelines, ensuring each grade suits its intended use. In twenty years of watching pharmaceutical quality control, ingredients meeting these standards make pharmacists’ jobs easier and patients’ routines safer.
Obstacles remain for global supply, especially where high humidity and inconsistent power grids threaten delicate products. Expanding access to pharmaceutical grade sodium stearate—through better logistics, research partnerships, and affordable pricing—helps health care teams deliver steady, reliable medication worldwide. While often overlooked, the workhorses among excipients like sodium stearate support trust, safety, and efficiency across the supply chain.
Sodium stearate has earned its place in the pharmaceutical world as a key ingredient, mainly because of its versatility. It shows up in plenty of tablets and creams, often as a lubricant or binder. Sodium stearate comes from a reaction involving stearic acid, a fatty acid found in vegetable and animal fats, and sodium hydroxide. The result looks pretty basic: a white, powdery substance with an unremarkable smell and a mild, soap-like feel. Yet, what it does inside pills and topical medicines matters a lot more than its appearance suggests.
Toss the letters BP, EP, and USP onto anything chemical, and you signal one thing: the strictest testing and quality controls. British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP) standards make sure what goes into the drug meets heavy demands for purity. This level of oversight protects patients from unwanted contaminants, fillers, or unexpected side effects. Each batch of sodium stearate meant for medical use must pass these filters, so the risk of impurities lowers dramatically compared to technical or food grades.
Across both the pharmaceutical and personal care industries, sodium stearate has racked up a long track record. The ingredient rarely triggers allergic reactions in healthy individuals; studies support a low toxicity profile when included at levels approved by health authorities. I’ve seen generics and branded products alike rely on sodium stearate to keep pills from sticking together and to make sure creams spread smoothly. Pharmacists and researchers keep a close eye on excipients, and sodium stearate hasn’t raised red flags in standard doses or topical applications.
Concerns arise anytime something ends up in a product people use for their health. Some people wonder about possible skin irritation (especially in large amounts or sensitive individuals) or if oral consumption could build up toxicity over time. Toxicology reviews have shown that sodium stearate does not accumulate in the body and typically leaves no negative effects when used as directed.
Manufacturers lean on established guidelines for how much sodium stearate ends up in each dose. Regulatory bodies, such as the FDA and EMA, set strict limits, relying on decades of human and animal studies. If a product hits the market in North America or Europe, auditors check sourcing, manufacturing methods, and final product analysis. This system catches outliers before anyone swallows a single tablet or squeezes out a tube of cream.
Peer-reviewed studies discuss how sodium stearate, when meeting pharmacopeial standards, poses minimal risk. Experts at the Cosmetic Ingredient Review and similar independent groups also monitor emerging data and public concerns. They update their guidance as new findings roll in. Right now, available evidence backs the use of sodium stearate in regulated medicines, provided production meets the most demanding specifications. Any deviation from those standards prompts follow-up testing and corrective steps.
The pharmaceutical industry won’t rest on its laurels with a substance just because it’s familiar. Safety data sheets evolve, new research appears, and oversight adapts to detect early trends. Open channels between regulators, manufacturers, and healthcare professionals keep information flowing about both good and bad outcomes. Should a problem surface, the response is immediate, whether it means lowering limits, switching suppliers, or pulling products from shelves.
Solutions stem from transparency and improvement. Popularity shouldn’t excuse complacency. Audits, robust testing, and embracing more transparent sourcing stop trouble before it starts. Continuous research into patient responses helps keep pace with emerging allergies or sensitivities. In my work, I’ve seen how honest communication between manufacturers, pharmacists, and patients puts everyone in the best position to maintain trust.
Most people who work in chemicals or pharmaceuticals bump into labels like BP, EP, or USP. These tags mean British Pharmacopoeia, European Pharmacopoeia, or United States Pharmacopeia. They shape how chemicals like sodium stearate show up in labs, factories, or medicine. A few letters, but they pack weight. Years ago, working in pharmaceutical manufacturing, I kept bumping into the headache of interpreting what “grade” someone needed for a given application. Lab results could get flagged for tiny differences, and the source almost always traced back to which pharmacopeia set the rules.
Every pharmacopoeia sets limits for impurities. USP sodium stearate may allow traces of certain metals at one level, while BP sets a stricter line for sulfated ash or free stearic acid. EP tries to harmonize, but subtle differences often turn up. Years ago, I chased down a batch that met USP but failed BP, over a narrow range for iron traces. These numbers can matter if a product goes into anything people swallow or inject. In that sense, no grade is “better” – just tuned for a different set of expectations.
It’s tempting to focus only on the “purity” number. But BP, EP, and USP consider more. They check on things like water solubility, pH in solution, even how the substance looks or smells. I once remember a soap manufacturer hunting for the right grade and getting tripped up by a spec that mentioned clarity in a 5% solution. BP had a clause about appearance the others skipped. Each pharmacopeia grew up alongside different manufacturing realities and traditions. They end up caring about different little quirks. USP will home in on substances used frequently in American drugmaking. The BP and EP focus more on Europe’s history and safety priorities.
Big differences don’t just stop with lab specs. Each pharmacopeia links to different documentation and audit rules. A supplier serving the US market faces FDA audits and will need the right batch records to keep up with USP. Supplying the UK or EU involves not just the BP or EP rules, but also extra certifications or data trails. During one site inspection, our team got tripped up by needing a retention sample for a BP-grade shipment—not a USP requirement at the time. These details chew up real time and money.
Getting the right grade comes down to knowing the end use and the regulatory environment. Soap and cosmetic makers can sometimes relax the standards and use food-grade or technical sodium stearate, which may cost less and still give good results for cleaning or gelling. Drug makers committed to a specific pharmacopoeia find themselves paying a premium for documentation, batch segregation, and tighter controls. For contract manufacturers and sourcing teams, looking for suppliers who clearly document compliance with the target grade avoids headaches. Conversations up front about pharmacopeial specs, batch testing, and retention needs keep things running smoother. Missing those points risks shipment delays or, worse, expensive product recalls.
Talking to colleagues around the world, everyone keeps calling for aligning these global standards. It would save costs, avoid confusion, and let smaller manufacturers join more markets. Some progress shows up with the ICH and efforts to bridge differences. Until then, anyone sourcing sodium stearate for a regulated product build-up still needs to respect the alphabet soup of BP, EP, and USP. They act as guardrails, protecting public health, but they also demand a little more savvy and attention to detail than most newcomers expect.
Sodium stearate steps into the pharmaceutical world as a fine white powder, known for its use as a lubricant, emulsifier, and stabilizer. Its utility puts it in a lot of products, and quality always traces back to how it's handled at every stage—including storage. Years around pharmacy supply rooms and pharmaceutical factories have taught me there’s no small detail in keeping materials stable and pure.
I’ve seen batches ruined just because someone left a drum unsealed in a damp storeroom. Sodium stearate absorbs water from air fast, which can turn a fluffy powder into clumps, tarnishing its performance and introducing contamination risks. The moment moisture sneaks in, companies face recalls, wasted stock, and costly investigations. Genuine mishaps like these have real effects—cash loss, disrupted schedules, and damaged reputations. Product recalls linked to improper storage appear every year in regulatory updates from bodies like the FDA and EMA.
A storeroom for pharma-grade sodium stearate isn’t like a garage. Don’t park it just anywhere. You need a spot where humidity and temperature hold steady. Indoor storage works best, with climate control. Aim for temperatures below 30°C (86°F), and keep humidity low—ideally under 50%. Dehumidifiers come in handy in muggy climates. A basic thermometer and hygrometer can give peace of mind. Factories stick to climate logs for a reason: tracking helps catch problems before they spiral.
Every supply manager I've worked with emphasizes sealed containers. Polyethylene-lined drums or heavy-duty resealable bags do more than tick boxes—they shut out moisture and airborne particles. Once you’ve opened a bulk container, reseal it tight after each use. Mark the date opened, and always rotate stock so the oldest gets used first. Cross-contamination turns up fast in factory audits, especially when containers sit open on busy workbenches.
Sodium stearate doesn’t play well with strong acids or oxidizers. Store it away from cleaning supplies, disinfectants, or any raw ingredients that might react. I once saw a product line stopped for days because someone stacked incompatible chemicals too close together, leading to accidental mixing. These setbacks aren’t just nuisances—they threaten worker safety and prompt expensive reminders from inspection agencies.
Modern systems demand more than locked doors. Accurate records matter. Label every batch with the manufacturer, date received, and expiry. Log storage conditions, and note who handled what, when. This practice helped one firm I knew dodge regulatory action—they could track every gram right back to the date it left the shelf. Inspections rarely bother folks with clear paper trails.
It often comes down to habits. Don’t leave bags open. Sweep up spills. Check for signs of water leaks, and never let containers touch the floor. Training matters just as much as fancy equipment. I’ve seen dedicated staff spot problems before a single dose leaves the gate, just because someone took pride in a tidy stockroom. In a workplace where detail keeps medicine safe, the little things make sure the bigger system works as intended.
Digging into the world of pharmaceutical ingredients, you run into sodium stearate popping up again and again. It’s one of those base materials labs and manufacturers rely on for everything from toiletries to tablets. But packaging isn’t an afterthought; it directly shapes quality, safety, and cost all the way down the line.
Years in supply chain management taught me that great products don’t survive lousy packaging. Nobody wants to watch a shipment arrive busted, with powder leaking or caking from humidity. Good packaging goes beyond regulatory checkboxes. Safe, thoughtful containers limit waste, keep staff safe, and mean less hassle dealing with authorities like the FDA or EMA.
Every day, I see three main styles for sodium stearate: fiber drums, polyethylene-lined bags, and high-density polyethylene (HDPE) containers. Each comes with its own strengths and struggles.
Fiber drums show up in larger operations. They run from 25 up to 100 kilograms per drum. A reinforced interior—typically lined with polyethylene—protects against moisture and chemical reactions. Strong, lightweight, and recyclable, these drums help facilities store or move powder safely, especially at scale. A tight-fitting lid and liner cut contamination. Having worked with big manufacturers, I can say opening a well-sealed drum in the middle of a humid summer feels like victory; the contents pour out clean and dry.
Polyethylene bags score highest for flexibility and ease. Smaller quantities—usually between 5 and 25 kilograms—move in heat-sealed, thick-gauge bags. Clear labeling and tamper-evident features stop mix-ups. It’s what I see most often in regional warehouses, where space is at a premium and workers want something light and stackable. Double-bagging isn’t just paranoia; it's a shield against leaks and accidental spills, especially in less controlled storage rooms.
HDPE containers sometimes get overlooked, but they shine where purity and longevity matter most. Think: clinical trials or shipments crossing borders. These containers, ranging from a couple of kilos up to around 20, keep out air, dust, and sunlight. The snap-shut lids provide peace of mind, especially in places vulnerable to pests or temperature swings. From my own pickups at customs, HDPE wins every time for standing up to rough handling.
Watching workers struggle with oversized packages highlighted another lesson. Lifting heavy drums without gear led straight to back injuries. Modular packaging—smaller drums or bags—cuts risks and speeds up movement. Most pharma-grade sodium stearate ends up handled in cleanrooms. Packages that open easily without tearing work best; no cloud of powder in the air, no fuss with contamination reports.
Improvements keep popping up. Desiccant pouches now line most interior bags and drums, preventing caking in tropical climates. QR-coded labeling helps track batch numbers and expiry dates, which is a lifesaver during audits or product recalls. Companies shifting toward recyclable materials help hospitals and labs hit sustainability goals without running into compatibility headaches.
After years in the trenches, I learned swift, careful packaging updates can slash waste, lower insurance premiums, and keep regulators happy. If a team tears open a box and the sodium stearate inside still meets spec, without mess or excess, then everyone down the line breathes a little easier—including the patients who rely on every quality control step.
Names | |
Preferred IUPAC name | sodium octadecanoate |
Other names |
Octadecanoic acid sodium salt Sodium salt of stearic acid Stearic acid sodium salt Stearate of soda Sodium octadecanoate |
Pronunciation | /ˈsəʊdiəm ˈstɪəreɪt biː piː iː piː juː ɛs piː ˈfɑːrmə ɡreɪd/ |
Identifiers | |
CAS Number | 822-16-2 |
Beilstein Reference | 3898731 |
ChEBI | CHEBI:32923 |
ChEMBL | CHEMBL1350 |
ChemSpider | 8650 |
DrugBank | DB01320 |
ECHA InfoCard | 03-211-265-790 |
EC Number | EC 209-163-7 |
Gmelin Reference | 7447 |
KEGG | C02573 |
MeSH | D017374 |
PubChem CID | 61790 |
RTECS number | WNLLV7A07A |
UNII | DPD6EDN2QG |
UN number | UN2924 |
CompTox Dashboard (EPA) | DTXSID8036723 |
Properties | |
Chemical formula | C18H35NaO2 |
Molar mass | 306.48 g/mol |
Appearance | White or almost white powder or crystalline powder |
Odor | Odorless |
Density | 0.95 g/cm3 |
Solubility in water | Slightly soluble in water |
log P | -1.3 |
Vapor pressure | Negligible |
Acidity (pKa) | pKa ~4.75 |
Basicity (pKb) | 11.0 |
Magnetic susceptibility (χ) | −32.0×10⁻⁶ cm³/mol |
Dipole moment | 1.6 D |
Thermochemistry | |
Std molar entropy (S⦵298) | 523.6 J·mol⁻¹·K⁻¹ |
Std enthalpy of formation (ΔfH⦵298) | -751.0 kJ/mol |
Std enthalpy of combustion (ΔcH⦵298) | -9395 kJ/mol |
Pharmacology | |
ATC code | S01XA20 |
Hazards | |
Main hazards | Causes skin and serious eye irritation. May cause respiratory irritation. |
GHS labelling | GHS07, Warning, Causes serious eye irritation. |
Pictograms | GHS07, GHS09 |
Signal word | Warning |
Hazard statements | H315: Causes skin irritation. H319: Causes serious eye irritation. |
Precautionary statements | Precautionary statements: P261, P264, P271, P272, P273, P280, P302+P352, P305+P351+P338, P332+P313, P362+P364, P501 |
NFPA 704 (fire diamond) | 2-0-0 |
Flash point | > 250°C |
Autoignition temperature | > 400°C |
Lethal dose or concentration | LD50 (Oral, Rat): > 5,000 mg/kg |
LD50 (median dose) | > 2000 mg/kg (Rat, oral) |
PEL (Permissible) | 15 mg/m3 (total dust) as PNOR (Particulates Not Otherwise Regulated), 5 mg/m3 (respirable fraction) OSHA PEL |
Related compounds | |
Related compounds |
Stearic Acid Sodium Palmitate Potassium Stearate Calcium Stearate Magnesium Stearate Sodium Laurate Sodium Oleate |